Vandebroek Sophie V.
SEC CIK 1442078 · EDGAR
BoughtSold
Most active insiders at IDXX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MAZELSKY JONATHAN JAY | Pres, CEO, Dir | — | $15.34M |
| 2 | Hunt Nimrata | EVP | — | $9.53M |
| 3 | FENNELL GEORGE | EVP | — | $7.34M |
| 4 | Erickson Michael G | EVP | — | $3.37M |
| 5 | Kingsley Lawrence D | Dir | — | $1.17M |
| 6 | Vandebroek Sophie V. | Dir | — | $920.3K |
| 7 | Emerson Andrew | EVP, CFO, Treas | — | — |
| 8 | Schreck Michael | EVP | — | — |
| 9 | Johnson Michael Perkins | EVP | — | — |
| 10 | Peacock Karen | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-11 17:11 | 2026-05-07 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $0.00 | +257 | 905 | +40% | $0 |
| M | 2026-05-11 16:05 | 2026-05-07 | RVTY | Revvity | Vandebroek Sophie V. | Dir | A - Grant | $0.00 | +2,280 | 7,368 | +45% | $0 |
| D | 2026-02-19 | 2026-02-17 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $333.90 | +945 | 2,112 | +81% | +$315.5K |
| DM | 2026-02-19 | 2026-02-17 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | S - Sale+OE | $628.62 | -1,464 | 648 | -69% | -$920.3K |
| D | 2025-05-13 | 2025-05-09 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | S - Sale+OE | $491.34 | -1,279 | 1,167 | -52% | -$628.4K |
| D | 2025-05-13 | 2025-05-09 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $283.59 | +1,279 | 2,446 | +110% | +$362.7K |
| D | 2025-05-08 | 2025-05-06 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $0.00 | +262 | 1,167 | +29% | $0 |
| M | 2025-05-01 | 2025-04-30 | RVTY | Revvity | Vandebroek Sophie V. | Dir | A - Grant | $0.00 | +2,412 | 5,088 | +90% | $0 |
| 2024-11-29 | 2024-11-27 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | S - Sale | $420.44 | -344 | 905 | -28% | -$144.6K | |
| 2024-11-29 | 2024-11-27 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | G - Gift | $0.00 | -224 | 1,249 | -15% | $0 | |
| D | 2024-05-08 | 2024-05-06 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $0.00 | +257 | 1,473 | +21% | $0 |
| M | 2024-05-02 | 2024-05-01 | RVTY | Revvity | Vandebroek Sophie V. | Dir | A - Grant | $0.00 | +2,195 | 1,458 | New | $0 |
| D | 2024-03-07 | 2024-03-05 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $245.79 | +1,404 | 2,620 | +115% | +$345.1K |
| D | 2024-03-07 | 2024-03-05 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | S - Sale+OE | $562.98 | -1,404 | 1,216 | -54% | -$790.4K |
| M | 2024-02-16 | 2024-02-15 | RVTY | Revvity | Vandebroek Sophie V. | Dir | A - Grant | $0.00 | +481 | 217 | New | $0 |
| D | 2023-05-15 | 2023-05-11 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $0.00 | +344 | 1,216 | +39% | $0 |
| DI | 2023-05-05 | 2023-05-04 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | G - Gift | $0.00 | -500 | 8,173 | -6% | $0 |
| D | 2023-05-05 | 2023-05-04 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $206.62 | +2,187 | 3,059 | +251% | +$451.9K |
| D | 2023-05-05 | 2023-05-04 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | S - Sale+OE | $469.02 | -2,187 | 872 | -71% | -$1.03M |
| D | 2022-05-13 | 2022-05-11 | IDXX | Idexx Laboratories | Vandebroek Sophie V. | Dir | M - OptEx | $0.00 | +224 | 872 | +35% | $0 |
Purchase Sale Sale after option exercise All abbreviations